Jazz Pharmaceuticals (JAZZ)

Company Ticker Sector | Industry Quality PAR
Jazz Pharmaceuticals JAZZ Healthcare | Biotechnology 97 17.5%
Current Price (01/18) $129.07
CAPS Rating (Rate this stock on CAPS) Foolcaps 3
Expected Income Statement
Current Sales 1,885.7
Sales Growth Forecast 13.0%
Net Profit Margin 48.6%
Projected Shares Outstanding 64.06
EPS - Five year Forecast $26.33
Average P/E Ratio 11.0
Projected Average Price $289.62
Price Appreciation (Annualized) 17.5%
Annual Dividend Yield 0.0%
Projected Annual Return 17.5%
Quality
Financial Strength 88 21.9
EPS Stability 92 23.0
Industry Sales Growth Rate 16.0% 10.1
Industry Net Profit Margin 25.5% 23.8
Calculated Quality Rating 78.8
Fool CAPS

Total Players

309 Outperforms
68 Underperforms
 

All-Stars (79)

64 Outperforms (81%)
15 Underperforms
 
Fundamental Data Updated: 12/07/2018

MIPAR 9.3%  
Sweet Spot 14.3% - 19.3%  

Top In Biotechnology

Ticker Quality PAR
JAZZ 97 17.5%
CBPO 76 15.8%
UTHR 78 11.8%
REGN 69 13.0%
BIIB 84 9.1%

Top In Healthcare

Ticker Quality PAR
ALGN 99 17.2%
JAZZ 97 17.5%
LMAT 85 17.0%
MD 84 17.0%
CVS 87 16.0%